美国慢性肾脏病患者照护质量趋势
该研究基于2006至2014年美国门诊就诊数据,评估慢性肾脏病(CKD)患者六项照护质量指标的变化趋势。结果显示血压和血糖控制不佳的患病率持续较高,他汀类使用率低且无改善,ACEI/ARB使用率下降但未达统计学意义。整体照护质量与指南推荐存在差距。
要点
- CKD患者血压控制不佳(>130/80 mm Hg)的患病率在2006-2008年为46%,2012-2014年为48%,无改善。
- 2012-2014年糖化血红蛋白>7%的未控制糖尿病患病率达40%。
- 50岁以上CKD患者他汀使用率从29%升至31%,仍较低且未达指南推荐。
核心结论
- 美国CKD患者血压和糖尿病控制不佳的患病率高,他汀使用率低且随时间无改善,与指南推荐不一致。
研究设计与样本
- 研究为2006至2014年美国全国性系列横断面研究,纳入确诊CKD的成人门诊就诊记录,未加权就诊次数7099次,加权代表186,961,565次就诊。
主要发现
- 2006-2008年未控制高血压(>130/80 mm Hg)患病率为46%,2012-2014年为48%,无统计学差异(P=0.50)。
- 2012-2014年糖化血红蛋白>7%的未控制糖尿病患病率为40%。
- ACEI/ARB使用率从2006-2008年的45%降至2012-2014年的36%,未达统计学意义(P=0.07)。
- 50岁及以上CKD患者他汀使用率从2006-2008年的29%变为2012-2014年的31%,无变化(P=0.92)。
关键数值与推荐
- 质量指标包括血压测量、未控制高血压(>130/80 mm Hg)、未控制糖尿病、高血压患者ACEI/ARB使用、年龄≥50岁他汀使用及非甾体抗炎药使用。
临床怎么用
- 肾内科医生应关注CKD患者血压和血糖达标情况,并依据指南评估他汀和ACEI/ARB的合理使用。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Improving the quality of CKD care has important public health implications to delay disease progression and prevent ESKD. National trends of the quality of CKD care are not well established. Furthermore, it is unknown whether gaps in quality of care are due to lack of physician awareness of CKD status of patients or other factors. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a national, serial, cross-sectional study of visits to office-based ambulatory care practices for adults with diagnosed CKD from the years 2006 to 2014. We assessed the following quality indicators: (1) BP measurement, (2) uncontrolled hypertension, (3) uncontrolled diabetes, (4) angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use among patients with hypertension, (5) statin use if age ≥50 years old, and (6) nonsteroidal anti-inflammatory drug use. Using multivariable linear regression and chi-squared analysis, we examined the change in quality performance over time. RESULTS: Between 2006 and 2014, there were 7099 unweighted visits for patients with CKD representing 186,961,565 weighted visits. There was no difference in the prevalence of uncontrolled hypertension (>130/80 mm Hg) over time (46% in 2006-2008 versus 48% in 2012-2014; P=0.50). There was a high prevalence of uncontrolled diabetes in 2012-2014 (40% for hemoglobin A1c >7%). The prevalence of ACEi/ARB use decreased from 45% in 2006-2008 to 36% in 2012-2014, which did not reach statistical significance (P=0.07). Statin use in patients with CKD who were 50 years or older was low and remained unchanged from 29% in 2006-2008 to 31% in 2012-2014 (P=0.92). CONCLUSIONS: In a nationally representative dataset, we found that patients with CKD had a high prevalence of uncontrolled hypertension and diabetes and a low use of statins that did not improve over time and was not concordant with guidelines.
引用
- Tummalapalli SL, Powe NR, Keyhani S, et al. Trends in Quality of Care for Patients with CKD in the United States. Clin J Am Soc Nephrol. 2019. PMID: 31296503. doi:10.2215/CJN.00060119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。